DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oxelumab
Oxelumab
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Targeting Costimulatory Molecules in Autoimmune Disease
Immunfarmakológia Immunfarmakológia
The Two Tontti Tudiul Lui Hi Ha Unit
W W W .Bio Visio N .Co M
(INN) for Biological and Biotechnological Substances
Head-To-Head Study of Oxelumab and Adalimumab in a Mouse Model of Ulcerative Colitis Based on NOD/Scid Il2rγ<Sup>Null<
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
(INN) for Biological and Biotechnological Substances
Biosimilar Antibodies & ELISA Kits
WO 2014/144600 A2 18 September 2014 (18.09.2014) P O P CT
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Top View
Innovating Antibodies, Improving Lives
A1088-Anti-OX40L (Oxelumab)
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Role of Biologics in the Management of Asthma
Research-Grade Biosimilars
Recombinant Engineered Antibodies
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Novel Biologicals for the Treatment of Allergic Diseases and Asthma
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
(INN) for Biological and Biotechnological Substances
Hitta Ett Inn Nohtunut Muut
Biosimilar Monoclonalantibodies
Downloaded from Mitochondrial Surface
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
CAPTURE Study 2089
(12) 按照专利合作条约所公布的国际申请w O 2016/050208
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri